VISION Data Report 2022

IV. Primary Ocular Melanoma

Did the patient have a biopsy?

Out of the 57% of patients who had a biopsy, in retrospect, how likely were they to make the same decision?

57%

43%

2%

NOT AT ALL

Yes

No

0%

A LITTLE BIT

Why did the patient not have a biopsy? Check all that apply.

6%

The 57% of patients who responded “Yes” reported whether results affected treatment and care:

SOMEWHAT

0%

QUITE A BIT

88%

No impact on screening

VERY MUCH

or further care 32%

4%

48%

UNKNOWN

Other 29%

42%

Concern for spread 15%

Out of the 43% of patients who did not have a biopsy, in retrospect, how likely were they to make the same decision?

Not offered 12%

10%

Unknown 10%

28%

NOT AT ALL

Side effects 2%

9%

A LITTLE BIT

Cost 0%

Yes

No Unknown

11%

SOMEWHAT

0%

QUITE A BIT

The 48% of patients who responded “Yes” reported: Changed frequency of follow-up 27% Other 30% Changed frequency of scans 29%

26% 26%

VERY MUCH

Offered adjuvant therapy 14%

UNKNOWN

2022 VISION Registry Data Report

25

Made with FlippingBook Ebook Creator